News

HealthDay on MSN4m
FDA Approves Twice-Yearly Yeztugo for Preexposure Prophylaxis to Cut HIV Risk
The U.S. Food and Drug Administration has approved Yeztugo (lenacapavir), an injectable HIV-1 capsid inhibitor, as ...
American Hospital Association48m
FDA approves first semiannual HIV prevention drug
The Food and Drug Administration has approved a new, first-of-its-kind semiannual HIV prevention medication, Gilead Sciences ...
'That's not freedom, that's fascism': Why queer Americans are fleeing red states for LA
As anti-LGBTIQ+ laws push queer and trans people from conservative states, West Hollywood with its vibrant drag scene, gender ...